Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury

European Journal of Pharmacology

Volumn 374, Issue 3, 1999, Pages 461-470

  Akar, Fatma ^a   Uydeş Dogan, B Sönmez ^b   Buharalioglu, C Kemal ^a   Gulcin Abban ^a   Heinemann, Akos ^c   Holzer, Peter ^c   Van De Voorde, Johan ^d  

^a GAZI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF GRAZ   (Austria)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Cromakalim; Diazoxide; Gastric artery; Glibenclamide; Indomethacin induced gastric injury; Neutrophil activation

Indexed keywords

CROMAKALIM; DIAZOXIDE; GLIBENCLAMIDE; INDOMETACIN; MYELOPEROXIDASE; N(G) NITROARGININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH BLOOD FLOW; STOMACH INJURY; STOMACH MUCOSA; STOMACH PROTECTION;

ANIMALS; ARTERIES; BLOOD GLUCOSE; BLOOD PRESSURE; CROMAKALIM; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC MUCOSA; GASTROINTESTINAL AGENTS; GLYBURIDE; HYPOGLYCEMIC AGENTS; INDOMETHACIN; MALE; NEUTROPHILS; PEROXIDASE; RATS; REGIONAL BLOOD FLOW; STOMACH; STOMACH DISEASES; VASODILATION; VASODILATOR AGENTS;

EID: 0344517086     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00277-0     Document Type: Article

References (47)

1. Akar F., Uydeş-Dogan B.S., Tufan H., Aşlamaci S., Köksoy C., Kanzik I. The comparison of the responsiveness of human isolated internal mammary and gastroepiploic arteries to levcromakalim: an alternative approach to the management of graft spasm. Br. J. Clin. Pharmacol. 44:1997;49-56.
2. Andrews F.J., Malcontenti-Wilson C., O'brien P.E. Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig. Dis. Sci. 39:1994;366-373.
3. Appleyard C.B., McCafferty D.-M., Tigley A.W., Swain M.G., Wallace J.L. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am. J. Physiol. 270:1996;G42-G48.
4. Ashley S.W., Sonnenschein L.A., Cheung L.Y. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. Am. J. Surg. 149:1985;53-59.
5. Auchampach J.A., Gross G.R. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J. Cardiovasc. Pharmacol. 23:1994;554-561.
6. Ding S.-Z., Lam S.-K., Yuen S.-T., Wong B.C.-Y., Hui W.-M., Ho J., Cho C.-H. Prostaglandin, tumor necrosis factor alfa and neutrophils: causative relationship in indomethacin-induced stomach injuries. Eur. J. Pharmacol. 348:1998;257-263.
7. Eberhart C.E., Dubois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:1995;285-301.
8. Esplugues J.V., Whittle B.J.R. Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa. Prostaglandins. 35:1988;137-148.
9. Fried J.F., Williams C.A., Bloch D.A., Michel B.A. Nosteroidal anti-inflammatory drug associated gastropathy: Incidence and risk factor models. Am. J. Med. 91:1991;213-222.
10. ATP channels. Br. J. Pharmacol. 121:1997;271-279.
11. Goswami S., Jain S., Santani D. Anti-ulcer activity of cromakalim (BRL 34915), a potassium-channel opener, against experimentally induced gastric and duodenal ulcers in rats and guinea-pigs. J. Pharm. Pharmacol. 49:1997;195-199.
12. Grisham M.B., Hernandez L.A., Granger D.N. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am. J. Physiol. 251:1986;G567-G574.
13. Grover G.J., Dzwonczyk S., Parham C.S., Sleph P.G. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused hearts and anesthetised dogs. Cardivasc. Drugs Ther. 4:1990;465-474.
14. Kauffman G.L., Aures D., Grossman M.I. Intravenous indomethacin and aspirin reduce basal mucosal blood flow in dogs. Am. J. Physiol. 238:1980;G131-G134.
15. Kitahura T., Guth P.H. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology. 93:1987;810-817.
16. Konturek S.J., Brzozowski T., Majka J., Pytko-Polonczyk J., Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur. J. Pharmacol. 239:1993;215-217.
17. Kozol R., Kopatsis A., Fligiel S.E.G., Czanko R., Callewaert D. Neutrophil-mediated injury to gastric mucosal surface cells. Dig. Dis. Sci. 39:1994;138-144.
18. Larsen K.R., Barattini P., Dayton M.T., Moore J.G. Effect of constant light on rhythmic gastric functions in fasting rats. Dig. Dis. Sci. 39:1994;678-688.
19. Lippe I.T., Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperemia due to acid back-diffusion. Br. J. Pharmacol. 105:1992;708-714.
20. Lopez-Belmonte J., Whittle B.J.R. The involvement of endothelial dysfunction, nitric oxide and prostanoids in the rat gastric microcirculatory responses to endothelin-1. Br. J. Pharmacol. 112:1994;267-271.
21. Mizumura T., Nithipatikom K., Gross G.J. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 92:1995;1236-1245.
22. Mulvany M.S., Halpern W. Contractile properties of small arterial resistance vessels in sponteneously hypertensive and normotensive rats. Circ. Res. 41:1977;19-26.
23. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in the arterial smooth muscle. Am. J. Physiol. 268:1995;C799-C822.
24. Pieper G.M., Gross G.J. EDM 52692 (Bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes. Immunopharmacology. 23:1992;191-197.
25. + channels? Trends Pharmacol. Sci. 14:1993;332-337.
26. + channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J. Pharmacol. Exp. Ther. 250:1989;261-271.
27. + currents in smooth muscle cells from rabbit mesenteric artery. Am. J. Physiol. 269:1995;C1112-C1118.
28. Rothlein R., Czaijkowski M., Kishimoto T.K. Intercellular adhesion molecule-1 in inflammatory response. Chem. Immunol. 50:1991;135-142.
29. Santucci L., Giansanti M., Brunori P.M., Di Matteo F.M., Morelli A. Pentoxifylline preventes indomethacin induced acute gastric mucosal damage in rats:role of tumour necrosis factor alfa. Gut. 35:1994;909-915.
30. Santucci L., Fiorucci S., Di Matteo F.M., Morelli A. Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology. 108:1995;393-401.
31. + channels in arterial smooth muscle. Science. 245:1989;177-180.
32. Takeuchi K., Okada M., Niida H., Okabe S. Possible mechanisms involved in gastric hypermotility caused by indomethacin in the rat: Role of glycoprivic response. Dig. Dis. Sci. 35:1990;984-992.
33. Takeuchi K., Ueshima K., Hironaka Y., Fujioka Y., Matsumoto J., Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion. 49:1991;175-184.
34. Takeuchi K., Niida H., Ohuchi T., Okabe S. Influences of urethane anesthesia on indomethacin-induced gastric mucosal lesions in rats. Relation to blood glucose levels. Dig. Dis. Sci. 39:1994;2536-2542.
35. Takeuchi K., Kato S., Hirata T., Nishiwaki H. Gastric motility and mucosal ulcerogenic responses induced by prokinetic drugs in rats under prostaglandin-deficient conditions. Dig. Dis. Sci. 42:1997;251-258.
36. Ueki S., Takeuchi K., Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig. Dis. Sci. 33:1988;209-216.
37. Van De Voorde J., Vanheel B. Influence of cytochrome P-450 inhibitors on endothelium-dependent nitro-L-arginine resistant relaxation and cromakalim-induced relaxation in rat mesenteric arteries. J Cardiovasc. Pharmacol. 29:1997;827-832.
38. Wallace J.L. Gastric ulceration:critical events at the neutrophil-endothelium interface. Can. J. Physiol. Pharmacol. 71:1993;98-102.
39. Wallace J.L., Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J. 10:1996;731-740.
40. Wallace J.L., Cirino G., De Nucci G., McKnight W., Mac-Naughton W.K. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am. J. Physiol. 256:1989;G661-G666.
41. Wallace J.L., Keenan C.M., Granger D.N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 259:1990;G462-G467.
42. Wallace J.L., Arfors K.E., McKnight G.W. A monoclonal antibody against the CD18 Leukocyte adhesion molecule prevents indomethacin-induced gastric damage in rabbit. Gastroenterology. 100:1991;878-883.
43. Wallace J.L., McKnight W., Miyasak M., Tamatani T., Paulson J., Anderson D.C., Granger D.N., Kubes P. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am. J. Physiol. 265:1993;G993-G998.
44. Walt R.P. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. New Engl. J. Med. 327:1992;1575-1580.
45. Whittle B.J.R., Lopez-Belmonte J. Actions and interactions of endothelins, prostacyclin and nitric oxide in the gastric mucosa. J. Physiol. Pharmacol. 44:1993;91-107.
46. Whittle B.J.R., Lopez-Belmonte J., Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol. 99:1990;607-611.
47. Yoshida N., Takemura T., Granger D.N., Anderson D.C., Wolf R.E., McIntire L.V., Kvietys P.R. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. Gastroenterology. 105:1993;715-724.